201 related articles for article (PubMed ID: 31111550)
1. Overexpression of miR-4286 is an unfavorable prognostic marker in individuals with non-small cell lung cancer.
An X; Ge J; Guo H; Mi H; Zhou J; Liu Y; Weiyue ; Wu Z
J Cell Biochem; 2019 Oct; 120(10):17573-17583. PubMed ID: 31111550
[TBL] [Abstract][Full Text] [Related]
2. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.
Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W
Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155
[No Abstract] [Full Text] [Related]
3. miR-4317 suppresses non-small cell lung cancer (NSCLC) by targeting fibroblast growth factor 9 (FGF9) and cyclin D2 (CCND2).
He X; Chen SY; Yang Z; Zhang J; Wang W; Liu MY; Niu Y; Wei XM; Li HM; Hu WN; Sun GG
J Exp Clin Cancer Res; 2018 Sep; 37(1):230. PubMed ID: 30227870
[TBL] [Abstract][Full Text] [Related]
4. MiRNA-195-5p Functions as a Tumor Suppressor and a Predictive of Poor Prognosis in Non-small Cell Lung Cancer by Directly Targeting CIAPIN1.
Zheng J; Xu T; Chen F; Zhang Y
Pathol Oncol Res; 2019 Jul; 25(3):1181-1190. PubMed ID: 30637589
[TBL] [Abstract][Full Text] [Related]
5. CiRS-7 targeting miR-7 modulates the progression of non-small cell lung cancer in a manner dependent on NF-κB signalling.
Su C; Han Y; Zhang H; Li Y; Yi L; Wang X; Zhou S; Yu D; Song X; Xiao N; Cao X; Liu Z
J Cell Mol Med; 2018 Jun; 22(6):3097-3107. PubMed ID: 29532994
[TBL] [Abstract][Full Text] [Related]
6. Knockdown of LncRNA PVT1 inhibits tumorigenesis in non-small-cell lung cancer by regulating miR-497 expression.
Guo D; Wang Y; Ren K; Han X
Exp Cell Res; 2018 Jan; 362(1):172-179. PubMed ID: 29133127
[TBL] [Abstract][Full Text] [Related]
7. Association between downexpression of MiR-203 and poor prognosis in non-small cell lung cancer patients.
Tang R; Zhong T; Dang Y; Zhang X; Li P; Chen G
Clin Transl Oncol; 2016 Apr; 18(4):360-8. PubMed ID: 26307752
[TBL] [Abstract][Full Text] [Related]
8. MiR-34b-3p represses cell proliferation, cell cycle progression and cell apoptosis in non-small-cell lung cancer (NSCLC) by targeting CDK4.
Feng H; Ge F; Du L; Zhang Z; Liu D
J Cell Mol Med; 2019 Aug; 23(8):5282-5291. PubMed ID: 31199581
[TBL] [Abstract][Full Text] [Related]
9. YBX1 regulated by Runx3-miR-148a-3p axis facilitates non-small-cell lung cancer progression.
Su H; Fan G; Huang J; Qiu X
Cell Signal; 2021 Sep; 85():110049. PubMed ID: 34082012
[TBL] [Abstract][Full Text] [Related]
10. circMTDH.4/miR-630/AEG-1 axis participates in the regulation of proliferation, migration, invasion, chemoresistance, and radioresistance of NSCLC.
Li YH; Xu CL; He CJ; Pu HH; Liu JL; Wang Y
Mol Carcinog; 2020 Feb; 59(2):141-153. PubMed ID: 31749230
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-100 is a potential molecular marker of non-small cell lung cancer and functions as a tumor suppressor by targeting polo-like kinase 1.
Liu J; Lu KH; Liu ZL; Sun M; De W; Wang ZX
BMC Cancer; 2012 Nov; 12():519. PubMed ID: 23151088
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of lncRNA MIR17HG reduced tumorigenicity and Treg-mediated immune escape of non-small-cell lung cancer cells through targeting the miR-17-5p/RUNX3 axis.
Zheng G; Ye H; Bai J; Zhang X
J Biochem Mol Toxicol; 2024 May; 38(5):e23715. PubMed ID: 38704830
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-381 serves as a prognostic factor and inhibits migration and invasion in non-small cell lung cancer by targeting LRH-1.
Tian C; Li J; Ren L; Peng R; Chen B; Lin Y
Oncol Rep; 2017 Nov; 38(5):3071-3077. PubMed ID: 29048619
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-15a induces cell apoptosis and inhibits metastasis by targeting BCL2L2 in non-small cell lung cancer.
Yang T; Thakur A; Chen T; Yang L; Lei G; Liang Y; Zhang S; Ren H; Chen M
Tumour Biol; 2015 Jun; 36(6):4357-65. PubMed ID: 25874488
[TBL] [Abstract][Full Text] [Related]
15. miR-768-3p is involved in the proliferation, invasion and migration of non-small cell lung carcinomas.
Xie Z; Chen W; Chen Y; Wang X; Gao W; Liu Y
Int J Oncol; 2017 Nov; 51(5):1574-1582. PubMed ID: 29048613
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-203 promotes the progression of non-small cell lung cancer via surviving.
Wang T; Li W; Li W; Liu L; Zhang H
J BUON; 2019; 24(2):591-598. PubMed ID: 31128011
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-383 is a tumor suppressor and potential prognostic biomarker in human non-small cell lung caner.
Shang Y; Zang A; Li J; Jia Y; Li X; Zhang L; Huo R; Yang J; Feng J; Ge K; Yang Y; Zhang Y; Jiang J
Biomed Pharmacother; 2016 Oct; 83():1175-1181. PubMed ID: 27551765
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of microRNA-1303 is a potential prognostic marker of non-small cell lung cancer.
Chen J; Jiang T; Yu B; Li T; Zhao P; Yuan L; Qi J
Cancer Biomark; 2020; 28(4):439-446. PubMed ID: 32508320
[TBL] [Abstract][Full Text] [Related]
19. microRNA-448 inhibits the progression of non-small-cell lung cancer through regulating IRS2.
Gao J; Feng X; Wang F; Wang J; Wang H; Li H; Zhang W; Hao L; Shi Z
J Cell Biochem; 2019 Aug; 120(8):13453-13463. PubMed ID: 30912183
[TBL] [Abstract][Full Text] [Related]
20. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer.
Zhou Y; Li S; Li J; Wang D; Li Q
Cell Physiol Biochem; 2017; 42(4):1431-1446. PubMed ID: 28715819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]